Research & University News

New angle on the CD95 receptor in cancer

A team of researchers in the US has reported that the CD95 receptor promotes tumour growth, a finding that advances work done at the German Cancer Research Center in Heidelberg, and at its spin-out, Apogenix GmbH.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany

Sanofi-Aventis in alliance with MIT

Sanofi-Aventis SA said that it has entered into a research alliance with the Massachusetts Institute of Technology’s Center for Biomedical Innovation that will support the translation of basic research into new healthcare products.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France

US grant to develop antibody against MRSA

The US National Institute of Allergy and Infectious Diseases has awarded a grant to a San Diego, California-based company to progress new technology for fighting S. aureus by disrupting a signalling process called quorum sensing.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States

Construction of synthetic bacterial cell reported

Scientists at the J. Craig Venter Institute in the US have reported the successful construction of a self-replicating, synthetic bacterial cell, technology that could have future application to pharmaceuticals.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States

US awards $3.4 million for S. aureus vaccine

The US National Institutes of Health have awarded $3.4 million to GlycoVaxyn AG of Switzerland and a researcher at the Harvard Medical School to carry out preclinical work on a new S. aureus vaccine for hospital-acquired infections.

 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland

Fraunhofer launches plant-based vaccine factory in the US

Two US centres of the Fraunhofer-Gesellschaft in Germany, together with Boston University and the biopharmaceutical company iBio, Inc, have launched a factory that uses non-genetically modified green plants to produce vaccines.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States

Scientists identify gene that plays a role in radiotherapy

Scientists in the UK have identified a gene that appears to enable tumour cells to survive radiotherapy. Suppression of the gene could therefore make current radiotherapies more effective, according to the charity, Cancer Research UK.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

AstraZeneca to collaborate with UPenn on Alzheimer’s disease

AstraZeneca Plc has concluded a collaborative research agreement with the University of Pennsylvania in the US to generate new drug candidates for Alzheimer’s disease. Financial details were not disclosed.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

UK cancer charity in deal with Cephalon Inc

Cancer Research Technology (CRT), the technology transfer arm of the charity, Cancer Research UK, has reached an agreement with Cephalon Inc of the US to develop new small molecule drugs targeting members of the protein kinase C family.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

King’s College London and Pfizer to research pain

Pfizer Inc has reached an agreement with King’s College London to site a small team of its scientists at the Wolfson Centre for Age-Related Disease at the King’s Guys campus in London to conduct basic research into the biology of pain.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States

Syndicate content